HUTCHMED (China)の空売り状況は、投資家がHUTCHMED (China)の株価下落に賭けている度合いを知ることができます。空売りデータは2週間ごとに更新されます。

HUTCHMED (China) (NASDAQ:HCM) 株価情報, 空売り情報

HUTCHMED (China)

HUTCHMED (China) Ltd is an innovative biopharmaceutical company engaged in the discovery, global development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.

HUTCHMED (China) Limited - American Depositary Shares

HUTCHMED (China) Ltd

HCM ACQUISITION CORP USD CL A ORD SHS

HCM ACQUISITION CORP USD UNITS CONSISTING ONE CL A ORD SH OF $0.0001 PAR VALUE &

HCM ACQUISITION CORP USD RED WTS

HEALTHIER CHOICES MGMT by Healthier Choices Management Corp.

Healthier Choices Management Corp

Holcim Ltd

Direxion Shares ETF Trust Direxion HCM Tactical Enhanced US ETF

Macro Economic Events

Macro Notification

News

Global

Economics

General

Trump Confirms He Had A Call With Putin; Discussed Ukraine, Middle East, Energy, Artificial Intelligence, Dollar With Putin

WIIM

COTY

Coty shares are trading lower after multiple firms cut their respective price targets on the stock.

GNRC

Generac Holdings shares are trading higher after the company reported better-than-expected Q4 adjusted EPS results.

On February 12, 2025, the Board of Directors of The Arena Group Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AREN#NYSE">AREN</a>) terminated the employment of Sara Silverstein as CEO, effective immediately. As the company rapidly transforms, the Board believes a new entrepreneurial operational strategy is necessary to execute its exciting growth plan. The Board thanks Sara for her contributions as CEO which includes stabilizing the company and has named Paul Edmondson as interim CEO. Paul was formerly the company's COO and is currently the President, Platform.

Management

AREN

The Arena Group Board Terminates CEO Sara Silverstein, Appoints Former COO Paul Edmondson As Interim CEO, Effective Immediately

RBC Capital analyst Joseph Pantginis reiterates Aptose Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APTO#NASDAQ">APTO</a>) with a Buy and maintains $2 price target.

Price Target

Reiteration

Analyst Ratings

APTO

RBC Capital Reiterates Buy on Aptose Biosciences, Maintains $2 Price Target

Oppenheimer analyst Matthew Biegler maintains Arvinas (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARVN#NASDAQ">ARVN</a>) with a Outperform and raises the price target from $40 to $45.

ARVN

Oppenheimer Maintains Outperform on Arvinas, Raises Price Target to $45

Federal Reserve

Fed Chair Powell Says Not Clear That Big Reductions In Federal Labor Force Would Affect Overall U.S. Labor Market; We Take This Case Of Alleged Espionage Very Seriously, Unaware Of Details Of The Case; We Have Very Strict Information Handling Requirements

Lightbridge Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LTBR#NASDAQ">LTBR</a>) shares are surging Wednesday after the company announced a significant milestone in its <a href="https://www.benzinga.com/quote/LTBR/news">nuclear fuel development efforts</a>.
What Happened: Lightbridge on Wednesday said it successfully performed a co-extrusion demonstration of a coupon sample consisting of an alloy of depleted uranium and zirconium with an outer cladding made of nuclear-grade zirconium alloy material at Idaho National Laboratory (INL).
The co-extrusion process involved pressing a metallic alloy billet encased in zirconium alloy cladding through a die to produce a cylindrical rod approximately 8 feet long. The uranium-zirconium alloy used in the demonstration rodlet is the same composition that Lightbridge plans to use for its future commercial Lightbridge Fuel product.
The company said the demonstration represents a key fabrication milestone in its strategic partnership with the U.S. Department of Energy&#8217;s (DOE) operating contractor Battelle Energy Alliance.
&#8220;This successful co-extrusion demonstration is a testament to the continuous progress we have made over the past year on demonstration of our fuel fabrication process in our collaborative efforts with INL,&#8221; said Scott Holcombe, vice president of engineering at Lightbridge.
&#8220;By integrating the uranium-zirconium alloy with nuclear-grade cladding material, we&#8217;re advancing the safety, efficiency, and performance of nuclear fuel, bringing us closer to commercialization and real-world deployment.&#8221;
The company&#8217;s progress paves the way for future production of coupon samples using enriched uranium and a planned irradiation testing program. The next steps in the process aim to generate irradiation performance data for Lightbridge&#8217;s advanced fuel and support regulatory licensing efforts for its commercial deployment.
LTBR Price Action: <a href="http://benzinga.com/quote/ltbr">Lightbridge shares</a> were up 24.9% at $13.54 at the time of publication Wednesday, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
This illustration was generated using artificial intelligence via Midjourney.

Movers

LTBR

Why Lightbridge Shares Are Soaring Wednesday

Politics

Majority Of U.S. Senate Approves Tulsi Gabbard As Director Of National Intelligence, Voting Continues

RBC Capital analyst Pammi Bir reiterates CT Real Est IT (TSX:<a class="ticker" href="https://www.benzinga.com/stock/CRT#TSX">CRT</a>) with a Sector Perform and maintains C$16 price target.

TSX:CRT

TSX:CRT/UN

RBC Capital Reiterates Sector Perform on CT Real Est IT, Maintains C$16 Price Target

Craig-Hallum analyst John Wilkin initiates coverage on Myriad Genetics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MYGN#NASDAQ">MYGN</a>) with a Buy rating and announces Price Target of $29.

Initiation

MYGN

Craig-Hallum Initiates Coverage On Myriad Genetics with Buy Rating, Announces Price Target of $29

U.S. House Speaker Johnson Says He Believes Republicans Will Have The Votes To Pass Newly Unveiled Budget Resolution; House Republicans Are Committed To Enacting Trump's Full Agenda Including His Tax Cut Objectives

Financial giants have made a conspicuous bearish move on Cisco Systems. Our analysis of options history for Cisco Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSCO#NASDAQ">CSCO</a>) revealed 12 unusual trades.
Delving into the details, we found 33% of traders were bullish, while 66% showed bearish tendencies. Out of all the trades we spotted, 5 were puts, with a value of $1,503,068, and 7 were calls, valued at $680,427.
<h3>Expected Price Movements</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $50.0 to $69.0 for Cisco Systems over the last 3 months. 
<h3>Insights into Volume &amp; Open Interest</h3>
In terms of liquidity and interest, the mean open interest for Cisco Systems options trades today is 4432.09 with a total volume of 14,627.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Cisco Systems's big money trades within a strike price range of $50.0 to $69.0 over the last 30 days.
<h3>Cisco Systems Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1739378827_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>CSCO</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$2.34</td>
<td>$2.19</td>
<td>$2.47</td>
<td>$60.00</td>
<td>$543.4K</td>
<td>4.6K</td>
<td>2.7K</td>
</tr>
<tr>
<td>CSCO</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$1.57</td>
<td>$1.52</td>
<td>$1.52</td>
<td>$57.50</td>
<td>$396.0K</td>
<td>3.3K</td>
<td>2.6K</td>
</tr>
<tr>
<td>CSCO</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$0.99</td>
<td>$0.92</td>
<td>$1.0</td>
<td>$55.00</td>
<td>$380.0K</td>
<td>8.7K</td>
<td>3.8K</td>
</tr>
<tr>
<td>CSCO</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>09/19/25</td>
<td>$7.55</td>
<td>$7.5</td>
<td>$7.5</td>
<td>$57.50</td>
<td>$374.2K</td>
<td>12.1K</td>
<td>499</td>
</tr>
<tr>
<td>CSCO</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$2.34</td>
<td>$2.23</td>
<td>$2.48</td>
<td>$60.00</td>
<td>$124.0K</td>
<td>4.6K</td>
<td>2.6K</td>
</tr>
</tbody>
</table>

<h3>About Cisco Systems</h3>
Cisco Systems is the largest provider of networking equipment in the world and one of the largest software companies in the world. Its largest businesses are selling networking hardware and software (where it has leading market shares) and cybersecurity software such as firewalls. It also has collaboration products, like its Webex suite, and observability tools. It primarily outsources its manufacturing to third parties and has a large sales and marketing staff-25,000 strong across 90 countries. Overall, Cisco employs 80,000 people and sells its products globally.
Having examined the options trading patterns of Cisco Systems, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>Where Is Cisco Systems Standing Right Now?</h3>
<ul>
<li>With a volume of 8,038,008, the price of CSCO is down -1.08% at $61.76. </li>
<li>RSI indicators hint that the underlying stock may be approaching overbought.</li>
<li>Next earnings are expected to be released in 0 days.</li>
</ul>
<h3>What The Experts Say On Cisco Systems</h3>
Over the past month, 1 industry analysts have shared their insights on this stock, proposing an average target price of $68.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from Citigroup has decided to maintain their Buy rating on Cisco Systems, which currently sits at a price target of $68. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Cisco Systems with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

Options

Markets

CSCO

Cisco Systems's Options: A Look at What the Big Money is Thinking

Investors with a lot of money to spend have taken a bearish stance on Boeing (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BA#NYSE">BA</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with BA, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 23 uncommon options trades for Boeing.
This isn't normal.
The overall sentiment of these big-money traders is split between 30% bullish and 43%, bearish.
Out of all of the special options we uncovered, 7 are puts, for a total amount of $552,340, and 16 are calls, for a total amount of $1,167,020.
<h3>What's The Price Target?</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $100.0 and $350.0 for Boeing, spanning the last three months.
<h3>Volume &amp; Open Interest Trends</h3>
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Boeing's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Boeing's significant trades, within a strike price range of $100.0 to $350.0, over the past month.
<h3>Boeing Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1739378821_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>BA</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/19/25</td>
<td>$19.0</td>
<td>$17.7</td>
<td>$19.0</td>
<td>$180.00</td>
<td>$366.7K</td>
<td>1.5K</td>
<td align="right">186</td>
</tr>
<tr>
<td>BA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$35.7</td>
<td>$35.3</td>
<td>$35.5</td>
<td>$150.00</td>
<td>$177.5K</td>
<td>1.2K</td>
<td align="right">52</td>
</tr>
<tr>
<td>BA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$14.8</td>
<td>$14.5</td>
<td>$14.6</td>
<td>$170.00</td>
<td>$176.6K</td>
<td>4.2K</td>
<td align="right">222</td>
</tr>
<tr>
<td>BA</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>05/16/25</td>
<td>$27.1</td>
<td>$27.05</td>
<td>$27.1</td>
<td>$160.00</td>
<td>$135.5K</td>
<td>1.1K</td>
<td align="right">51</td>
</tr>
<tr>
<td>BA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$12.1</td>
<td>$12.0</td>
<td>$12.0</td>
<td>$185.00</td>
<td>$134.4K</td>
<td>4.4K</td>
<td align="right">54</td>
</tr>
</tbody>
</table>

<h3>About Boeing</h3>
Boeing is a major aerospace and defense firm. It operates in three segments: commercial airplanes; defense, space, and security; and Global services. Boeing's commercial airplanes segment competes with Airbus in the production of aircraft that can carry more than 130 passengers. Boeing's defense, space, and security segment competes with defense contractors such as Lockheed and Northrop to create military aircraft, satellites, and weaponry. Global services provides aftermarket support to airlines.
<h3>Where Is Boeing Standing Right Now?</h3>
<ul>
<li>With a trading volume of 1,494,122, the price of BA is up by 0.17%, reaching $180.75.</li>
<li>Current RSI values indicate that the stock is may be approaching overbought.</li>
<li>Next earnings report is scheduled for 70 days from now.</li>
</ul>
<h3>Professional Analyst Ratings for Boeing</h3>
Over the past month, 5 industry analysts have shared their insights on this stock, proposing an average target price of $207.8.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Maintaining their stance, an analyst from Citigroup continues to hold a Buy rating for Boeing, targeting a price of $207. 
&#x2A; Consistent in their evaluation, an analyst from Susquehanna keeps a Positive rating on Boeing with a target price of $205. 
&#x2A; An analyst from UBS persists with their Buy rating on Boeing, maintaining a target price of $217. 
&#x2A; An analyst from Citigroup has decided to maintain their Buy rating on Boeing, which currently sits at a price target of $210. 
&#x2A; Maintaining their stance, an analyst from RBC Capital continues to hold a Outperform rating for Boeing, targeting a price of $200. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Boeing with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

Spotlight on Boeing: Analyzing the Surge in Options Activity

Financial giants have made a conspicuous bullish move on Lyft. Our analysis of options history for Lyft (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LYFT#NASDAQ">LYFT</a>) revealed 26 unusual trades.
Delving into the details, we found 69% of traders were bullish, while 30% showed bearish tendencies. Out of all the trades we spotted, 9 were puts, with a value of $554,346, and 17 were calls, valued at $1,184,197.
<h3>What's The Price Target?</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $8.0 and $23.0 for Lyft, spanning the last three months.
<h3>Analyzing Volume &amp; Open Interest</h3>
In today's trading context, the average open interest for options of Lyft stands at 2341.14, with a total volume reaching 28,541.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Lyft, situated within the strike price corridor from $8.0 to $23.0, throughout the last 30 days.
<h3>Lyft Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1739378815_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>LYFT</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/19/25</td>
<td>$2.41</td>
<td>$2.05</td>
<td>$2.05</td>
<td>$12.00</td>
<td>$205.0K</td>
<td>593</td>
<td>2.5K</td>
</tr>
<tr>
<td>LYFT</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>03/07/25</td>
<td>$0.8</td>
<td>$0.79</td>
<td>$0.79</td>
<td>$13.50</td>
<td>$159.1K</td>
<td>14</td>
<td>2.0K</td>
</tr>
<tr>
<td>LYFT</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>05/16/25</td>
<td>$2.22</td>
<td>$2.03</td>
<td>$2.17</td>
<td>$12.00</td>
<td>$141.0K</td>
<td>850</td>
<td>661</td>
</tr>
<tr>
<td>LYFT</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>04/17/25</td>
<td>$0.65</td>
<td>$0.64</td>
<td>$0.65</td>
<td>$15.00</td>
<td>$130.0K</td>
<td>3.9K</td>
<td>3.0K</td>
</tr>
<tr>
<td>LYFT</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>09/19/25</td>
<td>$2.43</td>
<td>$2.37</td>
<td>$2.43</td>
<td>$14.00</td>
<td>$121.5K</td>
<td>224</td>
<td>552</td>
</tr>
</tbody>
</table>

<h3>About Lyft</h3>
Lyft is the second-largest ride-hailing service provider in the us and Canada, connecting riders and drivers over the Lyft app. Incorporated in 2013 and public since 2019, Lyft offers a variety of rides via private vehicles, including traditional private rides, shared rides, and luxury ones. Besides ride-hailing, Lyft has entered the bike- and scooter-share market to bring multimodal transportation options to users.
Having examined the options trading patterns of Lyft, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>Lyft's Current Market Status</h3>
<ul>
<li>With a trading volume of 45,331,115, the price of LYFT is down by -5.77%, reaching $13.56.</li>
<li>Current RSI values indicate that the stock is is currently neutral between overbought and oversold.</li>
<li>Next earnings report is scheduled for 83 days from now.</li>
</ul>
<h3>Expert Opinions on Lyft</h3>
5 market experts have recently issued ratings for this stock, with a consensus target price of $15.2.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from BMO Capital has decided to maintain their Market Perform rating on Lyft, which currently sits at a price target of $15. 
&#x2A; Consistent in their evaluation, an analyst from Cantor Fitzgerald keeps a Neutral rating on Lyft with a target price of $14. 
&#x2A; An analyst from Evercore ISI Group persists with their In-Line rating on Lyft, maintaining a target price of $15. 
&#x2A; Consistent in their evaluation, an analyst from UBS keeps a Neutral rating on Lyft with a target price of $16. 
&#x2A; An analyst from Wedbush has decided to maintain their Neutral rating on Lyft, which currently sits at a price target of $16. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Lyft, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

LYFT

Behind the Scenes of Lyft's Latest Options Trends

Fed Chair Powell, Asked If Fed Will Continue To Follow Existing Law To Maintain Offices To Foster Inclusive Workplace, Says "Yes"

RBC Capital analyst Michael Harvey reiterates PrairieSky Royalty (TSX:<a class="ticker" href="https://www.benzinga.com/stock/PSK#TSX">PSK</a>) with a Outperform and maintains C$35 price target.

TSX:PSK

RBC Capital Reiterates Outperform on PrairieSky Royalty, Maintains C$35 Price Target

Billionaire<a href="https://www.benzinga.com/money/best-oil-stocks"> oil baron</a> Bill Koch is selling his 52-acre luxury compound in the world-renowned skier's paradise of Aspen, Colorado for $125 million. Although Koch's name might not be as well-known as that of the superstar jet set that has turned Aspen into one of the world's wealthiest enclaves, his financial might and political reach extend around the globe. Along with his late brother, Charles, Koch is one of the GOP's most important political benefactors.
The Koch brothers garnered quite a bit of fame throughout the 2000s by financially backing GOP initiatives, a position that also allowed them to shape significant aspects of GOP policy. The source of those funds stretches back to the early 20th century when the family patriarch, Fred Koch, made a small fortune helping Soviet leader Joseph Stalin modernize the fledgling Soviet Union's oil industry. Ironically, Koch and his sons are fierce anti-communists.&nbsp;
Don't Miss:
<ul>
<li>The secret weapon in billionaire investor portfolios that you almost certainly don't own yet. <a href="https://www.benzinga.com/money/masterworks-y2">See which asset class has outpaced the S&amp;P 500 (1995-2024) – and with near-zero correlation.</a></li>
<li>If there was a new fund backed by Jeff Bezos offering a <a href="https://www.benzinga.com/go/arrived-private-credit-yf">7-9% target yield with monthly dividends would you invest in it</a>?</li>
</ul>
Bill and Charles took over the family oil business after their father died and grew it into a multi-billion-dollar global powerhouse. Bill and Charles' personal fortunes rose with their company and they eventually branched out into real estate deals. According to the New York Post, Bill purchased the Aspen property in 2007 for $26.5 million. It proved to be just the opening phase of a massive real estate project.&nbsp;
Through the years, he purchased neighboring land parcels totaling and made numerous improvements that turned the property into something more akin to a private resort than a single estate. He added several luxurious guest cabins and outbuildings to the property, which is just 11 miles from Aspen's luxurious downtown shopping district, the Post said.&nbsp;
Trending: Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing —<a href="https://www.benzinga.com/money/boxabl-y2"> you can become an investor for $0.80 per share today.</a>
The Wall Street Journal estimates that the seven-bedroom, eight-bathroom lodge on the Koch property is 16,631 square feet and includes 30-foot ceilings along with sweeping views of Aspen's famous ski valley. Other luxury trappings include outdoor hot tubs with mountain views, a world-class fitness center, and a private network of roads and hiking trails that connect all the buildings on the estate.&nbsp;
Aspen's status as one of the world's premier ski destinations stretches back to the 1980s, and it has put a massive price premium on area real estate values. Even by that standard, the Koch property's value may never be higher and that is motivating his decision to sell. Speaking to The Journal, Koch said, "We looked at the strong housing market and figured it was time to let someone else enjoy it," when explaining why he re-listed the property.
See Also: This Jeff Bezos-backed startup will allow you to <a href="https://arrivedhomes.go2cloud.org/aff_c?offer_id=15&amp;aff_id=1006&amp;aff_sub=yahoo&amp;aff_sub2=byerscta100">become a landlord in just 10 minutes, with minimum investments as low as $100</a>.
According to the Post and The Journal, Koch attempted to sell the property for $100 million in 2015. He would eventually lower the price to $80 million and even offered to parcel it out. He reportedly sold 31 acres for $14.5 million but retained the main parcel and many of the buildings. Koch also generated<a href="https://www.benzinga.com/markets/25/02/43470819/heres-how-you-can-earn-100-in-passive-income-by-investing-in-alexandria-real-estate-stock"> passive income</a> from the estate by renting it out for $35,000/per night or $300,000 per month.&nbsp;
Aspen-area broker Steven Shane of Compass isy representing the property. In an interview with the Post Shane said, "While the ultra-wealthy may have many investment opportunities, none rival the profound richness of sharing time with loved ones across generations. Aspen's 125 Rooney Circle is one such property." It can all be yours if you love skiing and you can meet the $125 million asking price.&nbsp;
Wondering if your investments can get you to a $5,000,000 nest egg? Speak to a financial advisor today.<a href="https://smartasset.com/retirement/find-a-financial-planner?utm_source=benzinga&amp;utm_campaign=ben&amp;utm_content=y2_5MilNestEgg"> SmartAsset&#8217;s free tool matches you up with up to three vetted financial advisors who serve your area, and you can interview your advisor matches at no cost</a> to decide which one is right for you.
<h2 class="wp-block-heading">Arrived Achieved A Total Return of 34.7% On Their Biggest Sale Yet — Diversify Your Monthly Income Stream With Fractional Real Estate</h2>
<a href="https://arrivedhomes.go2cloud.org/aff_c?offer_id=15&amp;aff_id=1006&amp;aff_sub=yahoo&amp;aff_sub2=centennial">Arrived allows individuals to invest in shares of rental properties for as little as $100, providing the potential for monthly rental income and long-term appreciation without the hassles of being a landlord</a>. With over $1 million in dividends paid out last quarter and a growing selection of properties across various markets, Arrived offers an attractive alternative for investors seeking to build a diversified real estate portfolio.&nbsp;
In October 2024, Arrived sold The Centennial, achieving a total return of 34.7% (11.2% average annual returns) for investors. <a href="https://arrivedhomes.go2cloud.org/aff_c?offer_id=15&amp;aff_id=1006&amp;aff_sub=yahoo&amp;aff_sub2=centennial">Arrived aims to continue delivering similar value across our portfolio through careful market selection, attentive property management, and thoughtful timing in sales.</a>
Looking for fractional real estate investment opportunities? The <a href="https://www.benzinga.com/alternative-investments/real-estate">Benzinga Real Estate Screener</a> features the latest offerings.

Real Estate

Oil Tycoon And GOP Megadonor Bill Koch Selling His 52-acre Aspen, Colorado Compound For $125 Million

<a href="https://x.com/kaitlancollins/status/1889716749504823412" title="https://x.com/kaitlancollins/status/1889716749504823412">https://x.com/kaitlancollins/status/1889716749504823412</a>

CNN Reporter Kaitlan Collins Posts On X "President Trump had a call with Russian President Putin this morning, I'm told."

TE Connectivity plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TEL#NYSE">TEL</a>) shares are trading lower on Wednesday after the company agreed to acquire Richards Manufacturing Co. from Oaktree Capital Management and the Bier family in an all-cash <a target="_blank" href="https://www.benzinga.com/pressreleases/25/02/n43652224/te-connectivity-to-acquire-richards-manufacturing-to-expand-position-in-fast-growing-energy-market" rel="noreferrer noopener">transaction of around&nbsp;$2.3 billion</a>.
The deal enhances TE&#8217;s position in North America&#8217;s electrical utility market by integrating complementary products and leveraging Richards&#8217; expertise to capitalize on growth in underground electrical networks.
The company expects the acquisition to generate mid-teens returns on invested capital, driven by tax, revenue, and cost synergies.
The transaction is expected to close in TE Connectivity&#8217;s fiscal third-quarter ending June 2025.
The company plans to integrate business into its Industrial Solutions segment, contributing approximately $400 million in annual sales with <a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener">EBITDA margins in the mid-30% range</a>.
The deal is expected to boost TE&#8217;s sales growth and operating margins, with an anticipated 10 cents accretion to adjusted EPS in the first full year, excluding acquisition-related expenses.
TE Connectivity CEO&nbsp;Terrence Curtin said, &#8220;The acquisition of Richards Manufacturing aligns with our strategy and positions us to further capitalize on an accelerating grid replacement and upgrade cycle in&nbsp;North America, driven by aging infrastructure, the increased hardening of the network and the upgrades that are required to support the increase in energy demand.&#8221;
The company plans to finance the transaction through cash and additional debt. As of December&nbsp;27, TE&#8217;s cash and cash equivalents stood at $1.254 billion.
Last month, TE Connectivity reported first-quarter 2025 adjusted EPS of $1.95, surpassing the $1.89 estimate, while sales of $3.84 billion fell short <a target="_blank" href="https://www.benzinga.com/pressreleases/25/01/n43122031/te-connectivity-announces-first-quarter-results-for-fiscal-year-2025" rel="noreferrer noopener">of the $3.91 billion estimate</a>.
Investors can gain exposure to the stock via Investment Managers Series Trust III FPA Global Equity ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/FPAG#BATS">FPAG</a>) and Vesper US Large Cap Short-Term Reversal Strategy ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UTRN#NYSE">UTRN</a>).
Price Action: TE shares are down 2.07% at $145.78 at the last check Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com//node/43663018" target="_blank" rel="noreferrer noopener">WiSA Technologies Teams Up With Dolby To Enhance Wireless Audio; Stock Surges</a></li>
</ul>
Photo via Shutterstock.

Equities

Large Cap

FPAG

Vesper US Large Cap Short-Term Reversal Strategy ETF

UTRN

TE Connectivity Snaps Up Richards Manufacturing For $2.3 Billion: Details

Hutchmed (HCM) announces that it has entered into two agreements to divest its 45% equity interest in Shanghai Hutchison Pharmaceuticals for $608M ...

Hutchmed divests 45% interest in Shanghai Hutchison for $608M

Hutchmed (HCM) announces that the new drug application for the combination of Orpathys and Tagrisso for the treatment of patients with locally adva...

Hutchmed announces NDA acceptance in China, payment from AstraZeneca

HUTCHMED divests $608 million in non-core assets

Check out this morning's top movers from around Wall Street, compiled by The Fly.&nbsp; HIGHER – Topgolf Callaway (MODG) up 8% after Jefferies upgr...

Morning Movers: Neumora Therapeutics plummets after KOASTAL-1 misses endpoint

Chinese regulators accept NDA for Orpathys/Tagrisso combo

Hutchmed (HCM) announces that the supplemental new drug application for Orpathys has been granted approval by the China National Medical Products A...

Hutchmed announces NMPA approval for Orpathys supplemental new drug application

There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Annexon Biosciences (ANNX – Research Report), Immuno...

Analysts' Top Healthcare Picks: Annexon Biosciences (ANNX), Immunovant (IMVT)

Despite A Promising Future For Hutchmed, We Have Concerns About Development Of The Share Price (Rating Downgrade)

In a report released today, Alec Stranahan from Bank of America Securities reiterated a Buy rating on HUTCHMED (HCM – Research Report), with a pric...

Bank of America Securities Remains a Buy on HUTCHMED (HCM)

BofA raised the firm's price target on Hutchmed (HCM) to $27 from $26 and keeps a Buy rating on the shares. While noting it sees "some regulatory h...

Hutchmed price target raised to $27 from $26 at BofA

ANNX

ARCO

AZNCF

BABA

GOOG

GOOGL

HMDCF

HOOK

IMVT

MODG

NMRA

SIGA

SYNA

Press Releases

HUTCHMED Announces Appointment of Independent Non-executive Director and Member of Board Committee

HUTCHMED Announces Launch by Takeda of FRUZAQLA® (fruquintinib) in Japan

HUTCHMED Announces Continued Inclusion of ORPATHYS® (savolitinib) in the National Reimbursement Drug List in China at Current Terms

Health Care

HUTCHMED and Innovent Jointly Announce NMPA Conditional Approval for ELUNATE® (Fruquintinib) in Combination with TYVYT® (Sintilimab Injection) for the Treatment of Advanced Endometrial Cancer

Innovent and HUTCHMED Jointly Announce NMPA Conditional Approval for TYVYT® (Sintilimab Injection) in Combination with ELUNATE® (Fruquintinib) for the Treatment of Advanced Endometrial Cancer

HUTCHMED Announces Breakthrough Therapy Designation in China for ORPATHYS® and TAGRISSO® Combination in Certain Lung Cancer Patients After Disease Progression on EGFR Inhibitor Therapy

HUTCHMED to Receive Milestone Payment from Takeda following First European Reimbursement for FRUZAQLA® (fruquintinib)

Financing

HUTCHMED Announces US$608 million Divestment of Non-Core Joint Venture

HUTCHMED Announces NDA Acceptance in China with Priority Review Status for ORPATHYS® and TAGRISSO® Combination in Lung Cancer Patients with MET amplification After Progression on First-Line EGFR Inhibitor Therapy

Comments

HUTCHMED (China)

空売り

HUTCHMED (China) (NASDAQ:HCM) 株価情報, 空売り情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル